Shares of MeridianLink, Inc. (NYSE:MLNK – Get Free Report) have received a consensus rating of “Hold” from the seven ratings firms that are covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, four have given a hold recommendation and two have assigned a buy recommendation to the company. The average 1-year price objective among brokers that have covered the stock in the last year is $22.90.
MLNK has been the topic of several research analyst reports. Raymond James increased their price target on MeridianLink from $26.00 to $28.00 and gave the company an “outperform” rating in a report on Friday, November 8th. UBS Group raised MeridianLink from a “sell” rating to a “neutral” rating and increased their target price for the company from $18.00 to $22.50 in a report on Monday, November 11th.
Check Out Our Latest Stock Analysis on MLNK
MeridianLink Stock Performance
Insider Transactions at MeridianLink
In other MeridianLink news, major shareholder Thoma Bravo Ugp, Llc sold 650,000 shares of MeridianLink stock in a transaction that occurred on Friday, October 18th. The stock was sold at an average price of $21.05, for a total value of $13,682,500.00. Following the sale, the insider now owns 28,932,388 shares of the company’s stock, valued at $609,026,767.40. The trade was a 2.20 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, major shareholder Timothy Nguyen sold 1,701 shares of the stock in a transaction that occurred on Wednesday, November 27th. The shares were sold at an average price of $23.05, for a total value of $39,208.05. Following the transaction, the insider now owns 10,728,234 shares of the company’s stock, valued at $247,285,793.70. This represents a 0.02 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 6,864,860 shares of company stock valued at $144,991,819 over the last three months. Corporate insiders own 21.30% of the company’s stock.
Institutional Investors Weigh In On MeridianLink
Hedge funds have recently bought and sold shares of the business. nVerses Capital LLC purchased a new position in MeridianLink during the second quarter worth $41,000. SG Americas Securities LLC bought a new stake in MeridianLink during the 3rd quarter valued at about $231,000. Squarepoint Ops LLC purchased a new stake in MeridianLink in the 2nd quarter valued at about $336,000. The Manufacturers Life Insurance Company grew its stake in MeridianLink by 10.1% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 16,218 shares of the company’s stock worth $346,000 after acquiring an additional 1,490 shares in the last quarter. Finally, XTX Topco Ltd bought a new position in MeridianLink in the second quarter worth approximately $360,000. Hedge funds and other institutional investors own 82.65% of the company’s stock.
MeridianLink Company Profile
MeridianLink, Inc, a software and services company, provides software solutions for banks, credit unions, mortgage lenders, specialty lending providers, and consumer reporting agencies in the United States. The company offers MeridianLink One, a multi-product platform that can be tailored to meet the needs of customers as they digitally transform their organizations and adapt to changing business and consumer demands; MeridianLink Portal, a Point of Sale system that allows financial institutions to expand existing lending and deposit account; MeridianLink Opening, a cloud-based online account opening and deposit software solution; MeridianLink Consumer, a full loan solution suite to banks and credit unions; and MeridianLink DecisionLender, a loan origination software (LOS) for finance companies.
Further Reading
- Five stocks we like better than MeridianLink
- How is Compound Interest Calculated?
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- What is Forex and How Does it Work?
- Texas Instruments: The Old-School Tech Titan Still Delivering
- Top Stocks Investing in 5G Technology
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for MeridianLink Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MeridianLink and related companies with MarketBeat.com's FREE daily email newsletter.